Lubeck, Germany
Perfood, founded in 2017 and headquartered in Germany, is advancing the frontier of healthcare by integrating personalized nutrition with digital therapeutics. Known for its slogan, "Prescription digital therapeutics powered by personalized nutrition," the company aims to revolutionize medicine by offering software solutions that complement traditional drug treatments without side effects.
The company's flagship product, sinCephalea, offers an innovative approach to treat migraines through personalized, stable-glycemic nutrition. Since its inception, Perfood has built a solid pipeline of digital therapeutics rooted in proprietary technology, backed by significant research from the prestigious University of Lübeck. The company utilizes a comprehensive deep phenotyping dataset to tailor diagnostic and therapeutic solutions, focusing on nutrition as a key determinant of health.
Having attracted a €1.00M Early VC investment from BonVenture in May 2022, Perfood is well-positioned to scale its groundbreaking offerings and continue leading the charge in personalized, nutrition-based digital health solutions.
